NuVasive Inc. is a medical technology company founded in 1997 and headquartered in San Diego, California, U.S.. It was publicly traded on Nasdaq under the ticker NUVA but was acquired by Globus Medical in February 2023, making it a subsidiary. Prior to its acquisition, NuVasive had approximately 2,900 employees in 2023 and reported annual revenue of $1.2 billion as of December 31, 2022.
NuVasive focuses on developing, manufacturing, selling, and providing procedural solutions for spine surgery. Its comprehensive portfolio includes surgical access instruments, spinal implants made from various materials (e.g., allograft, titanium, PEEK), fixation systems, biologics, and enabling technologies such as software for surgical planning, navigation, and imaging solutions. The company also offers systems and services for intraoperative neuromonitoring (IOM) through NuVasive Clinical Services, which provides real-time insights into the nervous system during spine and brain-related surgeries. Additionally, NuVasive develops magnetically adjustable implant systems for spine and specialized orthopedic procedures.
Based on the provided case data, NuVasive Inc. is an operating company that defends against patent infringement claims. It has appeared as a defendant in one tracked case and has no appearances as a plaintiff. The single tracked case, Moskowitz Family LLC v. Nuvasive Inc., was filed in the Delaware District Court (D. Del.). This litigation posture is typical for an operating company that is a target of patent assertions rather than an entity primarily engaged in asserting patents.